SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-11-011587
Filing Date
2011-02-18
Accepted
2011-02-18 18:23:13
Documents
1
Period of Report
2010-12-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd302100.html 4  
1 FORM 4 rrd302100.xml 4 2906
  Complete submission text file 0001181431-11-011587.txt   4947
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O SORRENTO THERAPEUTICS, INC. 6042 CORNERSTONE CT., SUITE B SAN DIEGO CA 92121
Business Address
AFTING ERNST-GUENTER (Reporting) CIK: 0001234864 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52228 | Film No.: 11625913